BUSINESS● LOW1h ago · Nov 3, 2026, 2:59 AM
Jazz outlines $4.775B-$4.85B 2026 revenue guidance as Ziihera launch builds toward $3B-$5B peak sales potential
Seeking Alpha Tech · global
Jazz Pharmaceuticals has provided its 2026 revenue guidance, projecting significant sales potential from the launch of its Ziihera product. This financial outlook is important for understanding the company's expected growth and market position.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS8m agoAngel Oak Financial Strategies Income Term declares $0.115 dividendSeeking Alpha TechBUSINESS9m agoTennant raises quarterly dividend by 4.8% to $0.325/shareSeeking Alpha Tech